|
| Exchange Disseminated Time | Venus Remedies Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 24, 2011, inter alia, has approved the following;
1. Issue of fully convertible warrants on a preferential basis to Sunev Pharma Solutions Ltd., a promoter group company upto 5% of the total capital in a financial Year in accordance with SEBI (Substantial Acquisitions and Takeovers) Regulations, 1997. The same is also subject to applicable provisions of SEBI/Companies Act and approval of shareholders at the forthcoming Annual General Meeting.
2. Allotment of 12894 equity shares pursuant to request of FCCB holders for partly conversion of Foreign Currency Convertible Bonds at conversion price of Rs. 364/-. |
|
|